Td Asset Management Inc Bristol Myers Squibb CO Transaction History

Td Asset Management Inc

  • $102 Billion
  • Q2 2024

A detailed history of Td Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Td Asset Management Inc holds 1,744,501 shares of BMY stock, worth $92.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,744,501
Previous 1,648,245 5.84%
Holding current value
$92.8 Million
Previous $89.4 Million 18.95%
% of portfolio
0.07%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
BUY
$40.25 - $52.99 $3.87 Million - $5.1 Million
96,256 Added 5.84%
1,744,501 $72.4 Million
Q1 2024

May 08, 2024
BUY
$47.98 - $54.4 $2.05 Million - $2.32 Million
42,682 Added 2.66%
1,648,245 $89.4 Million
Q4 2023

Feb 12, 2024
BUY
$48.48 - $57.85 $5.13 Million - $6.12 Million
105,809 Added 7.06%
1,605,563 $82.4 Million
Q3 2023

Oct 27, 2023
SELL
$57.89 - $64.73 $1.15 Million - $1.28 Million
-19,849 Reduced 1.31%
1,499,754 $87 Million
Q2 2023

Aug 09, 2023
BUY
$63.71 - $70.74 $2.4 Million - $2.66 Million
37,601 Added 2.54%
1,519,603 $97.2 Million
Q1 2023

May 10, 2023
BUY
$65.71 - $74.53 $8.91 Million - $10.1 Million
135,533 Added 10.07%
1,482,002 $103 Million
Q4 2022

Feb 06, 2023
BUY
$68.48 - $81.09 $38.5 Million - $45.6 Million
562,092 Added 71.66%
1,346,469 $96.9 Million
Q3 2022

Nov 07, 2022
BUY
$0.13 - $76.84 $930 - $549,790
7,155 Added 0.92%
784,377 $56.2 Million
Q2 2022

Aug 04, 2022
SELL
$72.62 - $79.98 $3.65 Million - $4.02 Million
-50,295 Reduced 6.08%
777,222 $59.8 Million
Q1 2022

May 10, 2022
SELL
$61.48 - $73.72 $568,136 - $681,246
-9,241 Reduced 1.1%
827,517 $60.4 Million
Q4 2021

Feb 10, 2022
SELL
$53.63 - $62.52 $1.9 Million - $2.21 Million
-35,413 Reduced 4.06%
836,758 $52.2 Million
Q3 2021

Nov 09, 2021
SELL
$59.17 - $69.31 $993,937 - $1.16 Million
-16,798 Reduced 1.89%
872,171 $51.6 Million
Q2 2021

Aug 11, 2021
BUY
$61.91 - $67.42 $2.66 Million - $2.9 Million
43,008 Added 5.08%
888,969 $60.3 Million
Q1 2021

May 14, 2021
BUY
$59.34 - $66.74 $599,037 - $673,740
10,095 Added 1.21%
845,961 $53.4 Million
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $7.17 Million - $8.13 Million
-124,252 Reduced 12.94%
835,866 $51.8 Million
Q3 2020

Nov 10, 2020
BUY
$57.43 - $63.64 $13 Million - $14.4 Million
226,472 Added 30.87%
960,118 $57.9 Million
Q2 2020

Aug 13, 2020
SELL
$54.82 - $64.09 $1.09 Million - $1.28 Million
-19,915 Reduced 2.64%
733,646 $43.1 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $758,222 - $1.1 Million
-16,341 Reduced 2.12%
753,561 $42 Million
Q4 2019

Feb 11, 2020
BUY
$49.21 - $64.19 $4.74 Million - $6.18 Million
96,281 Added 14.29%
769,902 $49.4 Million
Q3 2019

Nov 07, 2019
SELL
$42.77 - $50.71 $1.16 Million - $1.37 Million
-27,060 Reduced 3.86%
673,621 $34.2 Million
Q2 2019

Aug 01, 2019
BUY
$44.62 - $49.34 $1.85 Million - $2.05 Million
41,450 Added 6.29%
700,681 $31.8 Million
Q1 2019

May 08, 2019
SELL
$45.12 - $53.8 $17.5 Million - $20.8 Million
-387,090 Reduced 37.0%
659,231 $31.5 Million
Q4 2018

Feb 01, 2019
SELL
$48.76 - $63.23 $217,664 - $282,258
-4,464 Reduced 0.42%
1,046,321 $54.4 Million
Q3 2018

Nov 01, 2018
SELL
$55.19 - $62.25 $1.67 Million - $1.88 Million
-30,280 Reduced 2.8%
1,050,785 $65.2 Million
Q2 2018

Jul 31, 2018
BUY
$50.53 - $62.98 $8.78 Million - $10.9 Million
173,807 Added 19.16%
1,081,065 $59.8 Million
Q1 2018

May 11, 2018
SELL
$59.92 - $68.98 $1.53 Million - $1.76 Million
-25,500 Reduced 2.73%
907,258 $57.4 Million
Q4 2017

Feb 02, 2018
SELL
$59.94 - $65.35 $1.53 Million - $1.67 Million
-25,575 Reduced 2.67%
932,758 $57.2 Million
Q3 2017

Nov 09, 2017
BUY
$55.23 - $63.74 $52.9 Million - $61.1 Million
958,333
958,333 $61.1 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email